Abivax SA Logo

Abivax SA (AAVXF)

OTC

Currency in USD
139.00
0.00 (0.00%)

Real-time Data

01:30 PM

Day's Range

139.00
139.00

52 wk Range

71.25
139.00

Overview - AAVXF - Abivax SA

Key Statistics

Valuation

Enterprise Value

12.36B

P/E (Trailing)

‪-28.77‬

PEG Ratio

‪1.08‬

Price / Sales (TTM)

‪2,465.09‬

Price / Book

‪22.17‬

EV / EBITDA

‪-41.59‬

Profitability

Profit Margin

‪0.00%‬

Operating Margin

‪-4,183.70%‬

Return on Assets

‪-44.65%‬

Return on Equity

‪-157.06%‬

Ownership

Shares Outstanding

79.29M

Float

69.35M

Held by Insiders

‪4.84%‬

Held by Institutions

‪50.10%‬

Price stats

Beta

‪-0.22‬

50-Day Avg

‪120.41‬

200-Day Avg

‪117.74‬

Dividends

Payout Ratio

‪0.00%‬

Shariah Compliance

Shariah Compliant

Report Date: Feb 20, 2025

Screened by Zoya using the AAOIFI methodology.

Market Cap - AAVXF - Abivax SA

Peers - AAVXF - Abivax SA

Peer Comparison

Compared with companies in Biotechnology listed on OTC.

Profile Summary - AAVXF - Abivax SA

About

Abivax SA is a France-based clinical-stage biotechnology company dedicated to developing innovative therapeutics that modulate the immune response in patients with chronic inflammatory diseases by harnessing the body's natural regulatory mechanisms, particularly through enhanced expression of microRNA-124. Its lead…

SectorHealthcare
IndustryBiotechnology
Employees69
Full company profile

The information on this page is provided for general informational purposes only and is not investment advice.

Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.

Last updated:

Stocks news

Track Global Markets in Real Time with UA Finance

Download the app now and access live financial data, expert analysis, and trusted economic news to follow stocks, forex, gold, and cryptocurrencies with ease.